Convener of Active Medical Product Surveillance Discussions (U13)

Post Date

June 24th 2009

Application Due Date

July 15th 2009

Funding Opportunity Number

RFA-FD-09-012

CFDA Number(s)

93.103

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Consumer Protection
Disaster Prevention and Relief
Education
Employment, Labor and Training
Environment
Health
Science and Technology and other Research and Development

Number of Awards

1

Eligibility Categories

Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)

Eligible Institutions The following organizations/institutions are eligible to apply: Non-profit organizations. Foreign institutions are not eligible to apply for conference grant support. An international conference can be supported through the U.S. representative organization of an established international scientific or professional society. Eligible Individuals Any individual with the skills, knowledge, and resources necessary to carry out the proposed activities as the Project Director (PD) is invited to work with his/her institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply. Other-Special Eligibility Criteria Number of Applications. Applicants may submit more than one application, provided they are scientifically distinct. Resubmissions. Resubmission applications are not permitted in response to this FOA. Renewals. Renewal applications are not permitted in response to this FOA.

Funding

• Estimated Total Funding:

  $600000

• Award Range:

  $600000 - $600000

Grant Description

This FOA, issued by the Office of Critical Path Programs (OCPP), Office of the Commissioner, Food and Drug Administration, solicits grant applications from neutral, independent institutions and/or organizations that propose methods for convening a broad range of stakeholders, to include those with relevant expertise, and that would support conferences and meetings to explore and address methodological, data development, technical, and communication issues related to active medical product surveillance and that would synthesize, summarize, and communicate findings from these conferences and meetings to a broad range of organizations and individuals that have the capability to use the information to further develop and create active medical product surveillance methods and systems.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Food and Drug Administration

• Agency Contact:

  Marc Pitts
  Electronic Research Liaison
  Phone 301-827-7162

• Agency Mailing Address:

  MARC.PITTS@FDA.HHS.GOV

• Agency Email Address:

  MARC.PITTS@FDA.HHS.GOV

• More Information:

  FEDERAL REGISTER NOTICE